Powerful Medical

🩺 “We improved care for over 3000 chest pain patients, and we're particularly proud to have reduced the door-to-balloon time in the STEMI equivalent cohort by 13 hours.” – Martin Herman, CEO of Powerful Medical. At the American Heart Association Health Tech Competition 2024, Martin introduced PMcardio, our AI-powered cardiovascular diagnostics platform. Trained on millions of patient outcomes, PMcardio diagnoses 39 cardiac conditions from any 12-lead ECG. Central to PMcardio is our AI-powered chest pain pathway, designed to transform acute heart attack care. By improving detection accuracy, streamlining care in clinical settings and reducing false positives, it sets a new standard in cardiovascular diagnostics. 🎥 Watch Martin’s winning presentation to learn more about PMcardio transforming cardiac care. #AHA2024 #PowerfulMedical #AIInHealthcare

🫀 “Our technology enables more accurate detection of acute heart attacks, with the potential to prevent over 12,000 excess deaths annually in the US,” – Robert Herman, MD, Chief Medical OfficerAt the American Heart Association Health Tech Competition 2024, Dr. Herman emphasized the importance of equitable access to accurate diagnostics and treatment of acute heart attacks, explaining how #PMcardio delivers the same high-quality diagnostics, regardless of patient demographics. 🎥 Watch his presentation for the Best Science Startup that earned recognition from top physicians, scientists, and industry leaders. 🔗 For the full video, click here: https://lnkd.in/d6BzNQ7E #AHA2024 #PowerfulMedical #AIInHealthcare

"This technology is really going to change and save lives, I know absolutely from first-hand experience!" - Star Jones, announcing Powerful Medical as the winner of the 2024 American Heart Association Health Tech Competition! PMcardio is an AI-powered ECG interpretation and clinical care coordination platform. It enables faster diagnosis and management of acute heart attacks, which affect over 800,000 Americans, like Star Jones, in the USA each year.

📍 At the American Heart Association Scientific Sessions 2024, Dr. Sara Diaz Saravia from Mount Sinai Morningside, New York, presented an external validation of #PMcardio in her research titled “Enhancing Detection of Occlusive Myocardial Infarction: AI Model Versus Traditional STEMI Criteria.” The results demonstrated how our #ECG AI model nearly doubles the sensitivity of traditional STEMI criteria for detecting occlusive myocardial infarction (OMI), enabling earlier and more accurate diagnoses and interventions. Its high specificity also shows potential to reduce false-positive catheterization lab activations while ensuring no true-positive STEMI-OMI cases are missed. 💡 Find out more about the clinical validations of PMcardio presented at AHA 2024 on our blog: https://lnkd.in/dfUdr-ks #AHA2024 #AIinHealthcare #ClinicalValidation

Last week, I had the privilege of attending a roundtable discussion hosted by the U.S. Embassy Bratislava and Citi. The event provided valuable insights into the challenges and opportunities of entering the U.S. market. Thank you to Ambassador Gautam Rana and the Citi team for fostering such an engaging and impactful discussion! #PowerfulMedical #USMarket #CITIBank

🩺 At #AHA2024, Dr. Timea Kisova brought critical attention to gender disparities in cardiac care. Her presentation, "Female Patients with Occlusive Myocardial Infarction without ST Elevation Experience Longer Delays in Receiving Emergent Reperfusion," revealed that women in the NSTEMI-OMI category face a staggering 4.4-hour longer delay in receiving life-saving treatments compared to men. These findings highlight the pressing need for equitable diagnostic strategies in ACS care. Dr. Kisova also emphasized the role of AI-powered tools like #PMcardio in bridging these gaps. By addressing diagnostic blind spots and ensuring unbiased care, these innovations have the potential to transform outcomes for all patients, regardless of gender or demographic factors. 🔗 Discover more about this important presentation and other highlights from #AHA2024 on our blog: https://lnkd.in/dfUdr-ks #CardiologyAI #PowerfulMedical

❤️ Powerful Medical is deeply honored to be the first company ever to win both the Best Overall and Best Science Pitch awards at the AHA Health Tech Competition. 🩺 With nearly 50% of adults in the U.S. affected by cardiovascular disease or stroke, the need for innovative solutions has never been more urgent. Our AI-driven technology was recognized for its exceptional diagnostic accuracy in real-world clinical settings and its transformative potential to enhance cardiovascular care. By providing unbiased, timely, and precise diagnostics, it ensures equitable care regardless of demographic factors. We are incredibly grateful to the American Heart Association, Nancy Brown, Star Jones, and the esteemed panel of judges for providing a platform to share our mission with the global cardiology community. This recognition reflects the dedication of the entire Powerful Medical team and reinforces our commitment to advancing cardiac care for patients worldwide through artificial intelligence. 📰 Find out more about our mission and this year’s competition in the AHA press release: https://lnkd.in/dvsCp3SU

💡 Robert Herman, MD took the stage at #AHA2024 to share exciting advancements in AI-powered cardiac care. In his presentation, "Deep-learning Assisted ECG-based Emergent Cathlab Activation: First Prospective Implementation of a Smartphone-based System," Dr. Herman highlighted our innovative AI solution that optimizes emergency pathways for chest pain patients. The AI-powered ECG model achieved an impressive 95.7% sensitivity in detecting OMI, significantly outperforming standard ECG machines at 47.8%. This technology has a potential to enhance ACS outcomes by improving acute coronary occlusion detection while reducing unnecessary cath lab activations. Dr. Herman also presented findings from "AI-powered Smartphone Application for Detecting Left Ventricular Systolic Dysfunction Using 12-lead ECG." This study showcased how the smartphone-integrated AI reliably detects reduced LVEF, with the potential to streamline patient pathways for echocardiographic evaluation and timely management. 🩺 We’re proud to contribute to advancing real-world clinical outcomes and improving patient care. Stay tuned for a more thorough breakdown on these impactful studies! #CardiologyAI #PowerfulMedical

Powerful Medical wins the 2024 American Heart Association Health Tech Competition with Best Overall and Best Science pitch! What a wonderful recognition, thank you #AHA2024.

🏆 We’re thrilled to announce Powerful Medical has been named the Best Science Pitch and Overall Winner at the AHA Health Tech Competition 2024! 🏆 This recognition, awarded on November 17, 2024, during the AHA Scientific Sessions in Chicago, highlights the transformative potential of #PMcardio, our AI-powered platform for cardiovascular diagnostics and care coordination. In the final round, competing against four other health startups, #PowerfulMedical captivated a distinguished panel of judges—including top physicians, scientists, and industry leaders—with its innovative approach to reshaping cardiovascular care. 💙 We’re honored to share this achievement and grateful to the American Heart Association for this incredible opportunity. 💡 Learn more about the competition and what made this year special: https://lnkd.in/dWv62zmj #AHA2024 #ScientificSessions #AIinHealthcare